News Select Year All Years 2026 (21) 2025 (37) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (21) BRACELET-1 (10) GOBLET (35) Search … May 12, 2010 Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results May 7, 2010 Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting April 23, 2010 Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial April 14, 2010 Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting April 8, 2010 Oncolytics Biotech(R) Inc. Announces Publication of Preclinical Research on Combination of Antiangiogenic Cancer Therapy with Oncolytic Virotherapy April 6, 2010 Media Advisory – Oncolytics Biotech(R) Inc. to Present at BioFinance 2010 March 30, 2010 Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 SCC Lung Cancer Trial March 9, 2010 Oncolytics Biotech(R) Inc. Announces 2009 Year End Results February 16, 2010 Oncolytics Biotech(R) Inc. Receives Approval from the U.K. MHRA to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers February 4, 2010 Media Advisory – Oncolytics Biotech(R) Inc. to Present at 12th Annual BIO CEO & Investor Conference Newer Page 56 of 71 Older